Histatin 5 variant reduces Candida albicans biofilm viability and inhibits biofilm formation
- PMID: 33596477
- PMCID: PMC7940551
- DOI: 10.1016/j.fgb.2021.103529
Histatin 5 variant reduces Candida albicans biofilm viability and inhibits biofilm formation
Abstract
Candida albicans is a commensal organism and opportunistic pathogen that can form biofilms that colonize surfaces of medical devices, such as implants, catheters, and dentures. Compared to planktonic C. albicans cells, cells in biofilms exhibit increased resistance to treatment. Histatin 5 (Hst-5) is an antimicrobial peptide that is natively secreted by human salivary glands and has strong antifungal activity against C. albicans. However, C. albicans produces secreted aspartic proteases (Saps) that can cleave and inactivate Hst-5, limiting its antifungal properties. We previously showed that residue substitutions K11R and K17R within Hst-5 improve its antifungal activity and prevent proteolytic degradation by Saps when treating planktonic C. albicans. Here, we investigated the use of the K11R-K17R peptide as an alternative therapeutic against C. albicans biofilms by assessing its ability to reduce viability of pre-formed biofilms and to inhibit the formation of biofilms and showed that K11R-K17R had improved activity compared to Hst-5. Based on these results, we incorporated K11R-K17R and Hst-5 into polyelectrolyte multilayer (PEM) surface coatings and demonstrated that films functionalized with K11R-K17R reduced the formation of C. albicans biofilms. Our results demonstrate the therapeutic potential of the K11R-K17R Hst-5 variant in preventing and treating biofilms.
Keywords: Antimicrobial peptides; Biofilm; Candida albicans; Histatin 5; Polyelectrolyte multilayer film.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest
AJK is an inventor on a patent that includes the K11R-K17R peptide. CMJ is an employee of the VA Maryland Health Care System. The views reported in this paper do not reflect the views of the Department of Veterans Affairs or the United States Government. CMJ has an equity position in Cellth Systems, LLC, and Avidea Technologies.
Figures





Similar articles
-
Engineering improved variants of the antifungal peptide histatin 5 with reduced susceptibility to Candida albicans secreted aspartic proteases and enhanced antimicrobial potency.FEBS J. 2018 Jan;285(1):146-159. doi: 10.1111/febs.14327. Epub 2017 Nov 29. FEBS J. 2018. PMID: 29143452 Free PMC article.
-
Effects of histatin 5 modifications on antifungal activity and kinetics of proteolysis.Protein Sci. 2020 Feb;29(2):480-493. doi: 10.1002/pro.3767. Epub 2019 Nov 20. Protein Sci. 2020. PMID: 31675138 Free PMC article.
-
Sensitivity of Candida albicans biofilm cells grown on denture acrylic to antifungal proteins and chlorhexidine.Arch Oral Biol. 2009 Jun;54(6):588-94. doi: 10.1016/j.archoralbio.2009.01.016. Epub 2009 Feb 27. Arch Oral Biol. 2009. PMID: 19249746 Free PMC article.
-
How does it kill?: understanding the candidacidal mechanism of salivary histatin 5.Eukaryot Cell. 2014 Aug;13(8):958-64. doi: 10.1128/EC.00095-14. Epub 2014 Jun 20. Eukaryot Cell. 2014. PMID: 24951439 Free PMC article. Review.
-
Biofilm of Candida albicans: formation, regulation and resistance.J Appl Microbiol. 2021 Jul;131(1):11-22. doi: 10.1111/jam.14949. Epub 2020 Dec 9. J Appl Microbiol. 2021. PMID: 33249681 Review.
Cited by
-
Quantifying the Antifungal Activity of Peptides Against Candida albicans.J Vis Exp. 2023 Jan 13;(191):10.3791/64416. doi: 10.3791/64416. J Vis Exp. 2023. PMID: 36715417 Free PMC article.
-
Antimicrobial Peptides with Anti-Candida Activity.Int J Mol Sci. 2022 Aug 17;23(16):9264. doi: 10.3390/ijms23169264. Int J Mol Sci. 2022. PMID: 36012523 Free PMC article. Review.
-
Exploring therapeutic avenues: mesenchymal stem/stromal cells and exosomes in confronting enigmatic biofilm-producing fungi.Arch Microbiol. 2023 Dec 8;206(1):11. doi: 10.1007/s00203-023-03744-0. Arch Microbiol. 2023. PMID: 38063945 Review.
-
Therapeutic potential of mesenchymal stem cells for fungal infections: mechanisms, applications, and challenges.Front Microbiol. 2025 Jan 30;16:1554917. doi: 10.3389/fmicb.2025.1554917. eCollection 2025. Front Microbiol. 2025. PMID: 39949625 Free PMC article. Review.
-
Strategies and opportunities for engineering antifungal peptides for therapeutic applications.Curr Opin Biotechnol. 2023 Jun;81:102926. doi: 10.1016/j.copbio.2023.102926. Epub 2023 Apr 5. Curr Opin Biotechnol. 2023. PMID: 37028003 Free PMC article. Review.
References
-
- Boudou T, et al., 2010. Multiple functionalities of polyelectrolyte multilayer films: new biomedical applications. Adv Mater. 22, 441–67. - PubMed
-
- Centers for Disease Control and Prevention, Antibiotic Resistance Threats in the United States, 2019. Vol. 2020, 2019.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials